News brief­ing: Sanofi ponies up more mon­ey to ex­pand pro­tein degra­da­tion col­lab with Nurix; Bio­gen fires shot at No­var­tis in new Spin­raza tri­al

Sanofi has agreed to shell out an ad­di­tion­al $22 mil­lion — bring­ing its to­tal cash in­vest­ment to $77 mil­lion — to ex­pand a dis­cov­ery pact with Nurix …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA